Entrada Therapeutics shares owned by Martingale Asset Management
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Martingale Asset Management
from 13F filings
Historical chart of Martingale Asset Management investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by Martingale Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $215k | 37k | 5.80 |
| 2025-06-30 | $265k | 40k | 6.72 |
| 2025-03-31 | $363k | 40k | 9.04 |
| 2024-12-31 | $668k | 39k | 17.29 |
| 2024-09-30 | $606k | 38k | 15.98 |
| 2024-06-30 | $395k | 28k | 14.25 |
| 2024-03-31 | $262k | 19k | 14.17 |
More positions owned by Martingale Asset Management
View all positions for Martingale Asset Management